CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Thomas Jefferson University
Northwestern University
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Roswell Park Cancer Institute
University of Chicago
Fred Hutchinson Cancer Center
Swiss Cancer Institute
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
German CLL Study Group
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Vanderbilt University Medical Center
Mayo Clinic
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Indiana University
Ohio State University Comprehensive Cancer Center
Boston Medical Center
Memorial Sloan Kettering Cancer Center
Asan Medical Center
Vanderbilt-Ingram Cancer Center
Northwestern University
Northwestern University
Northwestern University
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
Mayo Clinic
Hoag Memorial Hospital Presbyterian
NYU Langone Health
Fred Hutchinson Cancer Center
University of Arizona
Virginia Commonwealth University